Microenvironmental regulation of intestinal stem cells in the inflamed intestine

Yu Chen(Tongji Hospital), Fang Xiao(Tongji Hospital), Ursula Seidler(Medizinische Hochschule Hannover), Dean Tian(Tongji Hospital), Zhenghao Ye(Medizinische Hochschule Hannover)

Life Sciences

March 2, 2021

10.1016/j.lfs.2021.119298

Cited by 17

Related Papers

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

|New England Journal of Medicine|2016|1.8k

Probiotic Escherichia coli Nissle 1917 Inhibits Leaky Gut by Enhancing Mucosal Integrity

|PLoS ONE|2007|478

Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial

|The Lancet|2021|452

Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study

|The Lancet|2017|449

Intestinal Secretory Defects and Dwarfism in Mice Lacking cGMP-Dependent Protein Kinase II

|Science|1996|409